Kniss Laboratories Profile
Key Indicators
- Authorised Capital ₹ 12.00 Cr
as on 28-06-2024
- Paid Up Capital ₹ 10.29 Cr
as on 28-06-2024
- Company Age 36 Year, 1 Month
- Last Filing with ROC 31 Mar 2022
- Open Charges ₹ 40.47 Cr
as on 28-06-2024
- Satisfied Charges ₹ 1.24 Cr
as on 28-06-2024
- Revenue 8.34%
(FY 2022)
- Profit 66.86%
(FY 2022)
- Ebitda 3.92%
(FY 2022)
- Net Worth 2.07%
(FY 2022)
- Total Assets 26.06%
(FY 2022)
About Kniss Laboratories
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 12.00 Cr and a paid-up capital of Rs 10.29 Cr.
The company currently has active open charges totaling ₹40.47 Cr. The company has closed loans amounting to ₹1.24 Cr, as per Ministry of Corporate Affairs (MCA) records.
Varadarajan Dhivyalakshmi, Rajappan Ravi, and Muthiah Dhanalakshmi serve as directors at the Company.
- CIN/LLPIN
U24231TN1988PTC016466
- Company No.
016466
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 Nov 1988
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Chennai, Tamil Nadu, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Kniss Laboratories Private Limited offer?
Kniss Laboratories Private Limited offers a wide range of products and services, including Common Disease Medicines, Pharmaceutical Medicine, Pharmaceutical Syrup, Antibiotic Tablets & Capsules, Cefixime Tablet, Calcium Tablet, Calcium & Vitamin D3 Tablet.
Who are the key members and board of directors at Kniss Laboratories?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Muthiah Dhanalakshmi  | Managing Director | 17-Nov-1988 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Varadarajan Dhivyalakshmi | Director | 15-Jul-2020 | Current |
| Rajappan Ravi | Additional Director | 22-Aug-2023 | Current |
Financial Performance and Corporate Structure Insights of Kniss Laboratories.
Kniss Laboratories Private Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 8.34% increase. The company also saw a substantial improvement in profitability, with a 66.86% increase in profit. The company's net worth moved up by a moderate rise of 2.07%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Kniss Laboratories?
In 2022, Kniss Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 23 Feb 2024 | ₹10.00 Cr | Open |
Others Creation Date: 23 Feb 2024 | ₹9.50 Cr | Open |
Others Creation Date: 23 Oct 2019 | ₹5.50 Cr | Open |
How Many Employees Work at Kniss Laboratories?
Kniss Laboratories has a workforce of 46 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Kniss Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kniss Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
